Mineralys Therapeutics, Inc.
mineralystx.comLocations
Radnor, PA, USA · Raleigh, NC, USA · Fujisawa, Kanagawa, Japan
industry
Biotechnology
Size
51 - 200 employees
Stage
Other
founded in
2020
Mineralys Therapeutics Inc, a clinical-stage biopharmaceutical company, focuses on developing medicines to address conditions driven by elevated aldosterone levels. Their product candidate, lorundrostat, is an orally administered, selective aldosterone synthase inhibitor designed for individuals with uncontrolled or resistant hypertension who have difficulty achieving blood pressure targets with multiple antihypertensive medications.
Something looks off?Open jobs at Mineralys Therapeutics, Inc.
On-site & Remote
Job function
Seniority
Salary